Literature DB >> 32049277

Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters.

Wuen Ee Foong1, Jochen Wilhelm2, Heng-Keat Tam1, Klaas M Pos1.   

Abstract

OBJECTIVES: To investigate the role of Major Facilitator Superfamily (MFS)-type transporters from Acinetobacter baumannii AYE in tigecycline efflux.
METHODS: Two putative tetracycline transporter genes of A. baumannii AYE (tetA and tetG) were heterologously expressed in Escherichia coli and drug susceptibility assays were conducted with tigecycline and three other tetracycline derivatives. The importance of TetA in tigecycline transport in A. baumannii was determined by complementation of tetA in WT and Resistance Nodulation cell Division (RND) gene knockout strains of A. baumannii ATCC 19606. Gene expression of the MFS-type tetA gene and RND efflux pump genes adeB, adeG and adeJ in A. baumannii AYE in the presence of tigecycline was analysed by quantitative real-time RT-PCR.
RESULTS: Overproduction of TetA or TetG conferred resistance to doxycycline, minocycline and tetracycline in E. coli. Cells expressing tetA, but not those expressing tetG, conferred resistance to tigecycline, implying that TetA is a determinant for tigecycline transport. A. baumannii WT and RND-knockout strains complemented with plasmid-encoded tetA are significantly less susceptible to tigecycline compared with non-complemented strains. Efflux pump genes tetA and adeG are up-regulated in A. baumannii AYE in the presence of subinhibitory tigecycline concentrations.
CONCLUSIONS: TetA plays an important role in tigecycline efflux of A. baumannii by removing the drug from cytoplasm to periplasm and, subsequently, the RND-type transporters AdeABC and AdeIJK extrude tigecycline across the outer membrane. When challenged with tigecycline, tetA is up-regulated in A. baumannii AYE. Synergy between TetA and the RND-type transporters AdeABC and/or AdeIJK appears necessary for A. baumannii to confer higher tigecycline resistance via drug efflux.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32049277     DOI: 10.1093/jac/dkaa015

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

Review 1.  Biological Control of Acinetobacter baumannii: In Vitro and In Vivo Activity, Limitations, and Combination Therapies.

Authors:  Benjamin Havenga; Brandon Reyneke; Monique Waso-Reyneke; Thando Ndlovu; Sehaam Khan; Wesaal Khan
Journal:  Microorganisms       Date:  2022-05-19

2.  Update on Multidrug Resistance Efflux Pumps in Acinetobacter spp.

Authors:  Vanessa Kornelsen; Ayush Kumar
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

3.  Efflux Pump AcrAB Confers Decreased Susceptibility to Piperacillin-Tazobactam and Ceftolozane-Tazobactam in Tigecycline-Non-Susceptible Klebsiella pneumoniae.

Authors:  Junjie Li; Qingqing Xu; Sean Ogurek; Ziqiang Li; Peiyun Wang; Qing Xie; Zike Sheng; Minggui Wang
Journal:  Infect Drug Resist       Date:  2020-11-26       Impact factor: 4.003

4.  The Plasmid-Borne tet(A) Gene Is an Important Factor Causing Tigecycline Resistance in ST11 Carbapenem-Resistant Klebsiella pneumoniae Under Selective Pressure.

Authors:  Juan Xu; Zhongliang Zhu; Yanmin Chen; Weizhong Wang; Fang He
Journal:  Front Microbiol       Date:  2021-02-24       Impact factor: 5.640

5.  Antimicrobial resistance and population genomics of multidrug-resistant Escherichia coli in pig farms in mainland China.

Authors:  Zhong Peng; Zizhe Hu; Zugang Li; Xiaoxue Zhang; Chaoying Jia; Tianzhi Li; Menghong Dai; Chen Tan; Zhuofei Xu; Bin Wu; Huanchun Chen; Xiangru Wang
Journal:  Nat Commun       Date:  2022-03-02       Impact factor: 14.919

Review 6.  Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Ilda Barbu Czobor; Mariana Carmen Chifiriuc
Journal:  Microorganisms       Date:  2020-06-21

Review 7.  Acinetobacter baumannii Antibiotic Resistance Mechanisms.

Authors:  Ioannis Kyriakidis; Eleni Vasileiou; Zoi Dorothea Pana; Athanasios Tragiannidis
Journal:  Pathogens       Date:  2021-03-19

8.  The Co-occurrence of NDM-5, MCR-1, and FosA3-Encoding Plasmids Contributed to the Generation of Extensively Drug-Resistant Klebsiella pneumoniae.

Authors:  Ying Zhou; Wenxiu Ai; Yanhua Cao; Yinjuan Guo; Xiaocui Wu; Bingjie Wang; Lulin Rao; Yanlei Xu; Huilin Zhao; Xinyi Wang; Fangyou Yu
Journal:  Front Microbiol       Date:  2022-01-03       Impact factor: 5.640

9.  Binding of Tetracyclines to Acinetobacter baumannii TetR Involves Two Arginines as Specificity Determinants.

Authors:  Manuela Sumyk; Stephanie Himpich; Wuen Ee Foong; Andrea Herrmann; Klaas M Pos; Heng-Keat Tam
Journal:  Front Microbiol       Date:  2021-07-19       Impact factor: 5.640

10.  WGS based analysis of acquired antimicrobial resistance in human and non-human Acinetobacter baumannii isolates from a German perspective.

Authors:  Gamal Wareth; Christian Brandt; Lisa D Sprague; Heinrich Neubauer; Mathias W Pletz
Journal:  BMC Microbiol       Date:  2021-07-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.